Diabetic Macular Edema (DME) is an accumulation of fluid in the macula due to leaking blood vessels. The damages of the blood vessels result in vision impairment. This article summarizes the treatment options provided in Diabetic Retinopathy Guideline provided by The Royal College of Ophthalmologists. Multiple treatment options for DME are available now.
These include: Controlling of systemic risk factors: Patients with diabetic maculopathy should attain optimum blood pressure and glycemic control and for such patients consideration should be given to statin treatment unless there are medical contraindications, with consideration of the addition of a fenofibrate for those with type 2 diabetes. Photocoagulation: Laser photocoagulation treatment for DME has been the mainstay of treatment for diabetic macular edema since the early 1980s. Clinically significant macular edema is defined as…
